Test Price
2,800 AED✅ Home Collection Available
PRKCH Gene Cerebral Infarction Susceptibility Genetic Test in UAE | 2,800 AED | DHA Licensed
Executive Summary & Core Metrics
A 99.9% diagnostic sensitivity genetic test using Next Generation Sequencing (NGS) for assessing susceptibility to cerebral infarction, particularly lacunar strokes. Performed under ISO 9001:2015 certified processes at a DHA-licensed facility (License 1143). Includes mandatory pre-test genetic counselling with a consultant medical geneticist, VIP mobile phlebotomy with temperature-controlled cold-chain home collection (8 AM–11 PM daily), and post-test telephonic consultation. Home collection is available for whole blood, extracted DNA, or FTA card specimens.
Test Overview & Methodology
This advanced genetic analysis focuses on the PRKCH gene, a key regulator linked to increased susceptibility to cerebral infarction (lacunar stroke). Full gene sequencing via NGS provides comprehensive risk assessment, empowering neurologists and preventive medicine specialists to design individualized monitoring and lifestyle interventions.
| Feature | Our UAE Premium Test | Closest Alternative |
|---|---|---|
| Methodology | Next Generation Sequencing (NGS) – full gene coverage | Limited SNP genotyping or targeted PCR |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Analytic Sensitivity | 99.9% | ~95% (misses rare variants) |
| Pre‑Test Genetic Counselling | Mandatory session included (pedigree drawing) | Optional or not provided |
| Home Collection | VIP hospital‑grade, cold‑chain, 8 AM–11 PM daily | Standard lab visit or limited pickup |
| Price | 2,800 AED (all‑inclusive) | ~2,000 AED (counselling extra) |
Physician Insight & Safety Protocols
“As a consultant medical geneticist, I always emphasise that this genetic susceptibility test is a valuable risk‑stratification tool, but it must never replace a thorough clinical evaluation, brain imaging, or management of modifiable risk factors. A positive result does not guarantee a future stroke, and a negative result does not eliminate the possibility – clinical correlation is everything. Please continue all prescribed medications, especially antiplatelets or anticoagulants, and consult your physician before any adjustments.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
Do not discontinue or alter any prescribed medication without consulting your doctor. This test provides genetic risk information and does not constitute a recommendation to change ongoing therapy.
Safety Exclusion Criteria & Emergency Red Flags
Exclusion Criteria: Acute stroke symptoms or ongoing neurological emergency; minors without parental consent and documented medical necessity as per UAE regulations (including Federal Decree-Law No. 4 of 2016 on Medical Liability); individuals unable to provide valid informed consent. This test is not intended for acute diagnosis.
Emergency Red Flags – Seek immediate medical attention (call 998): Sudden unilateral weakness or numbness (face, arm, leg), facial drooping, slurred or garbled speech, sudden vision loss or double vision, severe headache with no known cause, dizziness with loss of balance. This genetic test will delay life‑saving treatment and must not be used for acute evaluation.
Patient FAQ & Clinical Guidance
1. What does the PRKCH gene test detect?
This NGS-based genetic test identifies pathogenic variants in the PRKCH gene that significantly increase susceptibility to cerebral infarction, particularly lacunar strokes. It provides a personalised risk profile to guide preventive care.
2. Who should consider this test?
Individuals with a strong family history of early-onset lacunar stroke or multiple unexplained cerebrovascular events, after mandatory pre-test genetic counselling with a consultant medical geneticist, should consider this analysis.
3. How is the test performed and what preparation is required?
A sample of whole blood, extracted DNA, or a single drop on an FTA card is collected during a temperature-controlled cold-chain home visit by a VIP mobile phlebotomist (8 AM–11 PM daily). No fasting is required. A mandatory pre-test genetic counselling session is arranged prior to sample collection.
UAE Regulatory & Data Privacy Adherence
Compliance & Data Protection
This service adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) for handling genetic information, and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields for health data security. All samples are processed in an ISO 9001:2015 certified facility (Cert: INT/EGQ/2509DA/3139). Your genetic data is stored securely and never shared without explicit informed consent.
Clinical & Logistical Metadata
| Test Name | PRKCH Gene Cerebral Infarction Susceptibility Genetic Test |
| Price (AED) | 2,800 AED (All-Inclusive VIP Package) |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood, Extracted DNA, or FTA Card |
| Methodology Used | Next Generation Sequencing (NGS) – Full Gene Coverage |
| ICD-10-CM Code | Z15.89 (Genetic susceptibility to other disease) |
| LOINC Code | 21794-4 (PRKCH gene analysis) |
| DHA Facility License & Laboratory Address | License 1143 – DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians